Methods for the design of vasomotor symptom trials: the Menopausal Strategies Finding Lasting Answers to Symptoms and Health network
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials. METHODS: Established in response to a National Institutes of Health request for applications, the network was charged with conducting rapid throughput randomized trials of novel and understudied available interventions postulated to alleviate vasomotor and other menopausal symptoms. Included are descriptions of and rationale for criteria used for interventions and study selection, common eligibility and exclusion criteria, common primary and secondary outcome measures, consideration of placebo response, establishment of a biorepository, trial duration, screening and recruitment, statistical methods, and quality control. All trial designs are presented, including the following: (1) a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of the selective serotonin reuptake inhibitor escitalopram in reducing vasomotor symptom frequency and severity; (2) a two-by-three factorial design trial to test three different interventions (yoga, exercise, and ω-3 supplementation) for the improvement of vasomotor symptom frequency and bother; and (3) a three-arm comparative efficacy trial of the serotonin-norepinephrine reuptake inhibitor venlafaxine and low-dose oral estradiol versus placebo for reducing vasomotor symptom frequency. The network's structure and governance are also discussed. CONCLUSIONS: The methods used in and the lessons learned from the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health trials are shared to encourage and support the conduct of similar trials and to encourage collaborations with other researchers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067
Rosen, C. B. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278597 · Cited by 6,593
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003) · Sleep · doi:10.1093/sleep/26.3.342 · Cited by 2,751
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Psychometric evaluation of the pittsburgh sleep quality index
Carpenter, J. S., & Andrykowski, M. A. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00298-5 · Cited by 1,618
Self-citationDevelopment of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
Validation of the Brief Pain Inventory for chronic nonmalignant pain
Tan, G., Jensen, M. P., Thornby, J. I., & Shanti, B. F. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2003.12.005 · Cited by 1,416
Gilbody, S., Richards, D., Brealey, S., & Hewitt, C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0333-y · Cited by 1,290
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095 · cited 1×
“Trials of pharmacologic and behavioral interventions in women with insomnia have suggested the Insomnia Severity Index to be sensitive in measuring treatment response.(30,31)”
BackgroundGold, E. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.5.463 · Cited by 861 · cited 1×
“4 years,(2) and menopausal symptoms peaked around the time of menopause.(3) In an earlier study, McKinlay et al(4) found that 96.”
BackgroundKrebs, E. E., Lorenz, K. A., Bair, M. J., Damush, T. M., Wu, J., Sutherland, J. M., Asch, S. M., & Kroenke, K. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0981-1 · Cited by 782 · cited 2×
“construct validity, and responsiveness to changes in outpatient populations.(19) In a randomized trial of adults with musculoskeletal pain, responsiveness to change in pain has been found to be equal or superior to several longer pain scales.”
BackgroundMethodSelf-citationDeRogatis, L., Clayton, A., Lewis-D'Agostino, D., Wunderlich, G., & Fu, Y. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00672.x · Cited by 740 · cited 2×
“We therefore included in all trials the Female Sexual Function Index(24) and a single item from the Female Sexual Distress Scale.(25) The full Female Sexual Distress Scale was implemented in MsFLASH 02.”
MethodHann (1998) · Quality of Life Research · doi:10.1023/a:1008842517972 · Cited by 500
Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes
Loprinzi, C. L., Sloan, J. A., Perez, E. A., Quella, S. K., Stella, P. J., Mailliard, J. A., Halyard, M. Y., Pruthi, S., Novotny, P. J., & Rummans, T. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1578 · Cited by 473
Methodologic lessons learned from hot flash studies.
Sloan, J. A., Loprinzi, C. L., Novotny, P. J., Barton, D. L., Lavasseur, B. I., & Windschitl, H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.23.4280 · Cited by 462
The Hot Flash Related Daily Interference Scale
Carpenter, J. S. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00353-0 · Cited by 292 · cited 2×
“Perceived hot flash interference was evaluated using the Hot Flash Related Daily Interference Scale.(10) This 10-item scale measures a woman_s perceptions of the degree to which VMS interfere with nine daily life activities; the 10th item measures interference with overall quality of life.”
MethodSelf-citationEfficacy of Escitalopram for Hot Flashes in Healthy Menopausal Women: A Randomized Controlled Trial
Freeman, E. W. (2011) · JAMA · doi:10.1001/jama.2010.2016 · Cited by 245
Self-citationSmith, M. T., & Wegener, S. T. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11409 · Cited by 200
Cited by
Lederman, S., Ottery, F. D., Cano, A., Santoro, N., Shapiro, M., Stute, P., Thurston, R. C., English, M., Franklin, C., Lee, M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00085-5 · Cited by 267
Prague, J. K., Roberts, R. E., Comninos, A. N., Clarke, S., Jayasena, C. N., Nash, Z., Doyle, C., Papadopoulou, D. A., Bloom, S. R., Mohideen, P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30823-1 · Cited by 204
Efficacy of exercise for menopausal symptoms: a randomized controlled trial
Sternfeld, B., Guthrie, K. A., Ensrud, K. E., LaCroix, A. Z., Larson, J. C., Dunn, A. L., Anderson, G. L., Seguin, R. A., Carpenter, J. S., Newton, K. M., et al. (2014) · Menopause · doi:10.1097/gme.0b013e31829e4089 · Cited by 184
Self-citationRamaswami, R., Villarreal, M. D., Pitta, D. M., Carpenter, J. S., Stebbing, J., & Kalesan, B. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3465-5 · Cited by 49
Self-citationOtte, J. L., Bakoyannis, G., Rand, K. L., Ensrud, K. E., Guthrie, K. A., Joffe, H., McCurry, S. M., Newton, K. M., & Carpenter, J. S. (2019) · Menopause · doi:10.1097/gme.0000000000001343 · Cited by 26
Self-citation
Metadata
- Authors
- Newton, K. M., Carpenter, J. S., Guthrie, K. A., Anderson, G. L., Caan, B., Cohen, L. S., Ensrud, K. E., Freeman, E. W., Joffe, H., Sternfeld, B., Reed, S. D., Sherman, S., Sammel, M. D., Kroenke, K., Larson, J. C., & LaCroix, A. Z.
- Venue
- Menopause
- Published
- 2014-01
- Volume
- 21
- Issue
- 1
- Pages
- 45-58
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2993539607
- Cited by
- 63
- References
- 18
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.